Phacilitate Leaders World 

2019 Speakers

2019 Speakers

  • Letter
    • P
  • Paolo De Coppi

    Paolo De Coppi

    Consultant Paediatric Surgeon / Reader & Head of Stem Cells & Regenerative Medicine, Great Ormond Street / UCL
  • Paolo Rizzardi

    Paolo Rizzardi

    Co-Founder, Chairman and CEO, Altheia Science
  • Partow Kebriaei

    Partow Kebriaei

    Medical Oncologist, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, MD Anderson Cancer Center
  • Pascale Belguise

    Pascale Belguise

    Director of Business Development, Polyplus transfection
  • Patricia Hurley

    Patricia Hurley

    Senior Director, PPD Consulting
  • Patrick  J. Hanley

    Patrick J. Hanley

    Director, Cellular Therapy Laboratory, Children’s National Health System
  • Patrick Rivers

    Patrick Rivers

    Principal, Aquilo Capital
  • Paul Stead

    Paul Stead

    Vice President Business Development, Adaptimmune
  • Paula Salmikangas

    Paula Salmikangas

    Director for Biopharmaceuticals & ATMPs, NDA ADvisory Services
  • Peihua Lu

    Peihua Lu

    Medical Executive President, Lu Daopei Hospital & Lu Daopei Institute of Haematology
  • Peter  Olagunju

    Peter Olagunju

    Vice President, Patient Operations, bluebird bio
  • Peter L. Hoang

    Peter L. Hoang

    President & Chief Executive Officer, Marker Therapeutics, Inc.
  • Peter Marks

    Peter Marks

    Director, Centre for Biologics Evaluation & Research, US Food and Drug Administration
  • Peter Robinson

    Peter Robinson

    VP, Strategic Alliances and Lead, Cell and Gene Therapy Consortium, Syneos Health
  • Peter Rubin

    Peter Rubin

    Endowed Professor & Chair of Plastic Surgery, Director UPMC Wound Healing Services, Professor of Bioengineering, University of Pittsburgh Medical Center
  • Peter Walters

    Peter Walters

    Lead Process Engineer, CRB
  • Phil Vanek

    Phil Vanek

    General Manager, Cell Bioprocessing, GE Healthcare
  • Philip Gotwals

    Philip Gotwals

    Head, Search and Evaluation, Strategic Alliances, Novartis Institute BioMedical Research (NIBR)
  • Pierluigi Paracchi

    Pierluigi Paracchi

    Co-Founder and CEO, Genenta
Get the latest industry insights and exclusive deals straight to your inbox

Get the latest industry insights and exclusive deals straight to your inbox